Sponsors

Sponsors

Medtronic

Medtronic
We lead global healthcare technology, boldly tackling the most challenging health problems. 

Our Mission — to alleviate pain, restore health, and extend life — unites a global team of more than 90,000 people. Every second of every day, our technologies help transform the lives of two people around the world.

Expect more from us. Medtronic. Engineering the extraordinary.

 

Boston Scientific

Boston Scientific
Boston Scientific is a global medical technology leader dedicated to transforming lives through innovative solutions that address unmet clinical needs. With a strong presence in neuromodulation, the company partners closely with clinicians and healthcare systems worldwide to advance therapies that improve outcomes and expand treatment possibilities for patients living with complex neurological conditions.

In Deep Brain Stimulation (DBS), Boston Scientific is committed to redefining precision, confidence, and personalization through Image Guided DBS. By integrating advanced imaging into the DBS workflow, Image Guided DBS provides physicians with greater anatomical insight and confidence throughout the therapy journey — from planning and lead placement to programming and long-term optimization. This approach supports more informed clinical decisions and helps tailor therapy to each patient’s unique anatomy and needs.

Boston Scientific’s DBS portfolio combines Image Guided DBS with advanced stimulation capabilities, intuitive programming, and MRI-conditional systems. Together, these technologies are designed to simplify clinical workflows, enable data-driven therapy optimization, and support consistent, high-quality care over time. For patients, this means a therapy experience built around precision, adaptability, and long-term confidence.

Innovation at Boston Scientific is grounded in collaboration. We work closely with physicians, researchers, and industry partners to translate scientific insight into practical, real-world solutions. Our continued investments in imaging-enabled workflows, digital health, remote programming, and next-generation neuromodulation reflect our belief that the future of DBS lies in smarter, more connected, and more personalized care ecosystems.

Beyond technology, Boston Scientific is driven by a deep commitment to ethical leadership, quality, and sustainability. We strive to operate responsibly, foster diversity and inclusion, and make a meaningful impact in the communities we serve. Through education, clinical evidence generation, and ongoing support, we aim to be a trusted partner throughout the entire patient journey.

At the 3rd DBS Society Congress, Boston Scientific is proud to engage with the global neuromodulation community to share knowledge, explore emerging science, and collaborate on shaping the future of DBS therapy — advancing precision care through Image Guided DBS.

FHC

FHC

“FHC, Inc. has served the neuroscience community for over 50 years in its mission to advance cranial microTargeting™ worldwide. With a guiding principle of innovation through collaboration, FHC designs, manufactures, and internationally markets products that provide customizable, pioneering solutions for neuroscientists, neurologists, and neurosurgeons. Respect for all business relationships and commitment to our communities are what drive us. We are proud to be a Maine-based company with a strong national and global sales and support network. FHC, Inc. features Neurocraft and Neuralynx brand products.”

Newronika

Newronika

Newronika delivers precision neuromodulation that adapts to each patient, minute by minute. Our patented, CE-marked aDBS® system continuously senses neural biomarkers and adjusts stimulation in real time, designed to reduce symptoms and side effects more reliably than conventional DBS. Starting with Parkinson’s disease — our system is designed to deliver more precise treatment for people living with neurological disorders.

Alpha Omega

Alpha Omega
Alpha Omega was established as a small engineering firm in Nazareth, Israel, in 1993 by Imad and Reem Younis, driven by a mission to lead the way to a better life.

The firm started to develop systems and solutions for companies and scientists in the Neuroscience fields. Then, it strengthened its core-competence in the fields of neural recording and stimulation, and built the infrastructure of Alpha Omega to grow and prosper.

Today, the firm offers systems and technologies to support the clinical needs across Deep Brain Stimulation (DBS) and Stereo-EEG (SEEG) implantation procedures.

Alpha Omega is committed to exceeding the expectations of Electrophysiologists, Neurosurgeons and Neurologists to making functional neurosurgery simple, effective and affordable, with its products, tools, algorithms, and services, continuing to introduce new solutions to contribute to the patient's healing journey.

Alpha Omega employs over hundred employees, in all its business units around the world, in Israel headquarters, USA, Germany, and China, united by a shared purpose of leading to better life everywhere